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Abstract
This study evaluated provider satisfaction in a sample of colorectal cancer (CRC)
survivors with and without Lynch syndrome (LS). Participants were case–case-matched
CRC survivors with (n = 75) or without (n = 75) LS (mean age of 55; range: 27–93).
Participants completed a mailed questionnaire assessing demographics, clinical characteristics, healthcare utilization, psychosocial variables, and provider satisfaction. LS
CRC survivors reported lower provider satisfaction scores on three subscales of the
Primary Care Assessment Survey: communication (78.14 vs. 83.96; P < 0.05), interpersonal treatment (78.58 vs. 85.30; P < 0.05), and knowledge of the patient (60.34
vs. 69.86; P < 0.01). Among LS CRC survivors, predictors for mean communication
and trust subscale scores were location of treatment and socioeconomic status. Higher
mean depression scores also were associated with trust, while social support predicted
higher satisfaction with communication. Sporadic CRC survivor satisfaction is driven
largely by age (communication, interpersonal treatment) and patient anxiety (communication), while seeing a provider more often was associated with increased satisfaction with knowledge of the patient. LS CRC survivors reported lower levels of
provider satisfaction than sporadic CRC survivors. LS survivors who received care
at The University of Texas MD Anderson Cancer Center, a comprehensive cancer
center (CCC), reported higher satisfaction than those receiving care at other institutions. Depressive symptoms and socioeconomic status may impact provider satisfaction
ratings. Exploration of other potential predictors of provider satisfaction should be
examined in this population. Additionally, further research is needed to examine the
potential impact of provider satisfaction on adherence to medical recommendations
in LS CRC survivors, particularly those being treated outside of CCCs.

Cancer Medicine 2017; 6(3):698–707
doi: 10.1002/cam4.1033

Introduction
Patients diagnosed with cancer often have increased healthcare needs, which may result in higher expectations of
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care. A greater understanding of predictors of patient
satisfaction with healthcare providers (HCPs) in an oncology setting can provide valuable information to providers
as well as researchers. There also may be differences
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between patients with sporadic colorectal cancer and those
with an inherited syndrome such as Lynch syndrome.
There is a significant gap in knowledge regarding the
patient–provider relationship in the oncology literature
generally and in the Lynch syndrome (LS) population
specifically. By understanding the predictors of patient
satisfaction with their HCP for individuals with LS, we
can better inform community health providers, develop
more targeted interventions, and ultimately improve screening and surveillance adherence. This study evaluates satisfaction with HCPs in a matched sample of LS and
sporadic CRC survivors.

What is LS?
LS is the most common hereditary colon cancer, accounting for approximately 3% of all colorectal cancer (CRC)
cases [1]. LS is characterized by predisposition to several
cancers, most commonly CRC and endometrial cancer,
and is caused by germline mutations in DNA mismatch
repair (MMR) genes, specifically MLH1, MSH2, MSH6,
PMS2, or in the EPCAM gene [2–7]. These mutations
can be identified through clinical genetic testing, ideally
initiated in individuals with cancer [8].
Compared with the general population, MMR mutation
carriers have a higher lifetime risk for several cancers;
CRC risk ranges from 20 to 69% for men and 10 to
52% for women, with risks varying based on mutated
gene [9–13]. Women with LS also have a 40–60% lifetime
risk for developing endometrial cancer [2, 3, 8, 14].
Individuals with LS are at increased risk for other malignancies, including ovarian, stomach, small bowel, hepatobiliary tract, pancreatic, urinary tract, brain, and skin
cancers [3, 8, 14]. To mitigate these risks, affected individuals are advised to follow high-
risk surveillance and
cancer management guidelines [8, 15]. Screening recommendations include annual or biennial colonoscopy initiated at age 20–25 years or 2–5 years younger than the
earliest known case in the family, which has proven clinical
benefits, and annual endometrial screening initiated at
age 30–35 years. In women who have completed childbearing, prophylactic endometrial surgery also is recommended [3, 4, 8, 15].

Patient–provider relationships in oncology
settings
Patients’ satisfaction with their healthcare providers (HCPs)
has been shown to be positively correlated with adherence
to screening, surveillance, and treatment [16, 17].
Improving adherence to screening for LS individuals is
particularly important, as their screening regimens are
demanding and nonadherence can be life-threatening [16,

© 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
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17]. One important aspect of patients’ HCP satisfaction
is the nature of the patient–provider relationship [16–20].
Prior research on CRC survivors’ satisfaction with HCP
has focused on treatment satisfaction or healthcare service
quality, whereas little is known about characteristics of
the patient–provider relationship, nor how such characteristics influence patient satisfaction in this population
[16, 21–23].
For individuals with LS, one critical factor that impacts
a HCP’s ability to appropriately counsel patients with
LS is a significant gap in knowledge about genetics and
LS. HCP not only need to be adequately informed about
the characteristics of LS, but also need to be able to
obtain comprehensive medical and family histories, make
referrals to genetics services, and recommend appropriate
screening and medical management [4, 24–29]. Data
from prior studies show that physicians lack knowledge
in these key areas. One study focusing on gastroenterologists found that when presented with a family history
consistent with LS, 79% of physicians could identify the
syndrome, 26% recommended genetic counseling for the
patient, and only 16% advised appropriate screening [30].
In a study that compared knowledge of LS among a
sample of gastroenterologists and primary care physicians,
findings showed that gastroenterologists were more likely
to elicit a family history of colorectal neoplasia (93%
vs. 63%), implement appropriate screening strategies for
individuals with LS (73% vs. 50%), and refer a patient
at risk for LS for genetic testing (72% vs. 57%) [29].
However, both groups of physicians demonstrated less-
than-
optimal compliance with recommended screening
guidelines and with the notification of at-risk relatives
[29]. HCP knowledge in these areas is key in the LS
population as research has indicated that simply informing an individual of his or her mutation status and
cancer risk may not motivate behavior change, and may,
in fact, be a barrier to screening if the individual believes
that they have no control over whether he or she develops cancer [31–33].
A variety of tools have been used to evaluate patient
satisfaction with their HCPs in the general population,
but few have been used in oncology settings [34]. The
variation in measures and populations used to assess patient
satisfaction with HCP makes it difficult to compare satisfaction results across studies. Thus, the literature examining
the patient–provider relationship in oncology, and how it
relates to satisfaction, remains limited [34]. To more clearly
articulate the patient–provider relationship in oncology and
LS populations, we must first understand the predictors
of patient satisfaction with their HCP [21, 34].
Several studies have identified trust and physician knowledge as important predictors of patient satisfaction with
HCP in oncology settings [14, 17, 19, 34]. One study,
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focusing specifically on LS mutation carriers, examined
barriers and facilitators of screening and management in
this population [14]. Both trust and physician knowledge
of family history were interdependent factors that affected
LS patients’ perception of their HCPs. Study participants
expressed higher levels of trust when physicians were both
aware of their family history and recognized the importance
of high-
risk cancer surveillance [14]. These factors also
influenced participation in recommended screening regimens
[14]. However, further research is needed to fully examine
how patient trust can be effectively improved [17].
Other relationship factors, including communication
and interpersonal behavior, also have been used to assess
patient satisfaction with HCPs in oncology settings [16,
18, 20, 35]. One study found that through effective communication, HCPs were able to positively impact health-
related attitudes and behaviors regarding adherence [18].
A particularly salient finding from this study was that
communication style was the only patient or HCP variable that could both influence screening adherence and
be taught [18]. In addition to improving patient satisfaction with their HCPs and health behaviors, patient–provider
communication may be related to patients’ overall quality
of life [16, 20]. Providers’ interpersonal and socio-
emotional behaviors, such as empathy, engagement, and
attentiveness, also appear to be predictors of patients’
perception of their HCPs [20].
The aim of this study was to evaluate satisfaction with
HCPs in a matched sample of LS and sporadic CRC
survivors. Directly comparing these two populations enabled us to identify factors related to provider satisfaction
that may be unique to the LS population while also adding to the limited literature on patient satisfaction with
their providers in an oncology setting.

Materials and Methods
Participants
This study was approved by the Institutional Review Board
at the University of Texas MD Anderson Cancer Center
(MD Anderson). Participants were CRC survivors with
LS or sporadic cancer who were matched on age, sex,
race/ethnicity, cancer stage, geography, and time since
diagnosis using a LS case–sporadic case design. Survivors
with LS were recruited from MD Anderson (n = 33)
and through social media (n = 42) and had to have
tested positive for a LS mutation. Sporadic CRC survivors
were recruited from the tumor registry at MD Anderson
(n = 75). All participants were 18 years of age or older
and were able to read and speak English. Patients with
CRC were limited to those with a diagnosis of CRC
from 6 months to 5 years prior to enrolling in the study.
700
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LS participants recruited through MD Anderson were
screened for eligibility using medical records and those
recruited through social media were screened by self-
report over the phone prior to enrolling in the study.
Using information from their medical records, we excluded
sporadic CRC patients with a personal or family history
of familial adenomatous polyposis (FAP) and inflammatory bowel disease, or those who had a first-degree relative
with CRC.

Data collection methods
Data were collected using a mailed, self-
administered
questionnaire. Eligible survivors received a packet containing an introductory letter, questionnaire, and a self-
addressed stamped return envelope. Nonrespondents
received an identical follow-up mailing at 3 weeks after
the initial mailing and a follow-up reminder phone call
at 6 weeks with the option to complete the questionnaire
over the phone. Those who completed the questionnaire
received a $10 gift card as compensation.

Study measures
Demographic data were obtained through self-
report.
Medical data were obtained through medical records and
self-report.
The location of treatment for each patient was noted
in an open-ended question and then coded as an NCI-
designated comprehensive cancer center (CCC) or other
healthcare institution. All individuals seen at a CCC received
care at MD Anderson. Healthcare utilization was measured
using a 4-item scale developed by the Stanford Chronic
Disease Self-Management Study [36]. This measure quantifies physician, emergency room, and hospital visits.
The 20-
item Center for Epidemiologic Studies
Depression (CES-D) scale measured depressive symptoms
[37]. A clinical psychologist was available for referral for
individuals who were identified as showing high levels
of depressive symptomatology. Anxiety was measured
using the State-Trait Anxiety Inventory (STAI). Both the
CES-D and STAI are widely used in clinical and medical
populations and have good internal consistency and reliability [37, 38]. Social support and satisfaction with social
support were assessed using a scale by Krause and
Borawski-Clark [39].
We used four scales from the Primary Care Assessment
Survey (PCAS) to measure the patient’s relationship with the
treating provider for our outcome, including communication,
interpersonal treatment, patient trust, and provider’s knowledge of the patient (comprehensive) [40–42]. The instructions
for the PCAS ask the patient to “think about the one healthcare provider who is most involved in coordinating his or

© 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
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Table 1. Demographics n (%) [95% confidence interval].
Characteristic

LS (n = 73)

Sporadic (n = 70)

P-value

Mean Age (SD)

52.6 (12.1)
[49.8–55.5]
40 (54.8%)
[0.431–0.665]
33 (45.2%)
[0.335–0.569]
61 (83.6%)
[0.749–0.923]
12 (16.4%)
[0.078–0.252]
67 (91.8%)
[0.853–0.982]
6 (8.2%)
[0.018–0.147]
60 (82.2%)
[0.732–0.912]
13 (17.8%)
[0.078–0.252]
46 (63.0%)
[0.517–0.744]
27 (37.0%)
[0.256–0.483]
27 (37.0%)
[0.256–0.483]
23 (31.5%)
[0.206–0.424]
23 (31.5%)
[0.206–0.424]
17 (23.3%)
[0.134–0.332]
19 (26.0%)
[0.157–0.363]
37 (50.7%)
[0.389–0.624]

54.1 (11.3)
[51.4–56.8]
40 (57.1%)
[0.453–0.690]
30 (42.9%)
[0.310–0.547]
54 (77.1%)
[0.671–0.872]
16 (22.9%)
[0.128–0.329]
66 (94.3%)
[0.887–0.999]
4 (5.7%)
[0.001–0.113]
63 (90.0%)
[0.828–0.972]
7 (10.0%)
[0.078–0.252]
42 (60.0%)
[0.482–0.718]
28 (40.0%)
[0.282–0.518]
34 (48.6%)
[0.366–0.606]
23 (32.9%)
[0.216–0.441]
13 (18.6%)
[0.092–0.279]
15 (21.4%)
[0.116–0.313]
23 (32.9%)
[0.216–0.441]
32 (45.7%)
[0.338–0.577]

(P = 0.46)

Gender

Female
Male

Marital Status

Married
Not married

Race

White
Non-white

Child

Have children
No children

Work

Working full-or part-time
Not working

Education

Less than college
College degree
Postgraduate

Financial Situation

Financial difficulty
No spare money
Can afford special things

(P = 0.78)

(P = 0.34)

(P = 0.56)

(P = 0.18)

(P = 0.71)

(P = 0.16)
(P = 0.86)
(P = 0.08)
(P = 0.79)
(P = 0.37)
(P = 0.56)

Not all percentages and totals add up due to missing data.

her care” when responding to the questions. The measure
does not specifically ask for provider specialties. In prior
research, these scales have correlated well with outcomes of
care such as adherence and satisfaction [40–42].

Statistical analysis
Bivariate differences were evaluated between LS and
sporadic survivors on known or expected factors related
to provider satisfaction using chi-square, and completed
with SAS version 9.3 [43]. Regression models were estimated separately for LS and sporadic survivors to independently evaluate the factors that predicted provider
satisfaction. Distinct models were estimated for each of
the four PCAS subscales (communication, interpersonal
treatment, trust, and provider’s knowledge of the patient)
in each group.

© 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Results
Demographic and bivariate analysis
From the overall sample of 75 LS CRC and 75 sporadic
CRC survivors, we excluded seven who were missing at
least one component of our outcome measure, the PCAS
scale. Our analytic sample for this study included 73 LS
CRC and 70 sporadic CRC survivors. The average age of
participants was in their early 50s with a mean age of
52.6 years for patients with LS and 54.1 for patients with
sporadic cancer, with more females than males (54.9% and
57.1%, respectively) and LS more likely to be married
(83.6% and 77.1%, respectively, for LS versus sporadic).
Demographic characteristics can be seen in Table 1. Due
to the matching of LS and sporadic cases, there were no
significant demographic differences between groups. We
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Table 2. Healthcare experiences, social support, and patient satisfaction mean scores n (%) [95% confidence interval].
Mean/(SD)
Location of treatment

Comprehensive cancer centers
Noncomprehensive cancer centers

Healthcare experiences (Number)

Doctor visits (past 6 months)

Psychosocial metrics

Emergency room visits
(past 6 months)
Different hospital stays
(past 6 months)
Total overnight hospital stays (past
6 months)
CES-D Scale score
Trait score
State score

Social support scales

Krause social support satisfaction
scale
Lubben social support family scale
Lubben social support friend scale

PCAS scores

Communication
Interpersonal
Trust
Comprehensive

LS (n = 73)

Sporadic (n = 70)

P-value

33 (45.2%)
[0.335–0.569]
40 (54.8%)
[0.431–0.665]
3.834 (3.782)
[2.951–4.716]
0.329 (1.334)
[0.018–0.640]
0.219 (0.917)
[0.005–0.433]
0.930 (4.489)
[-0.117–1.978]
8.918 (7.496)
[7.169–10.667]
66.023 (9.946)
[63.702–68.345]
32.535 (8.308)
[30.597–34.474]
9.405 (2.162)
[8.901–9.910]
24.901 (4.973)
[23.741–26.062]
23.647 (5.503)
[22.363–24.931]
78.137 (18.120)
[74.194–82.957]
78.575 (18.778)
[74.194–82.957]
76.795 (15.496)
[73.179–80.410]
60.342 (21.071)
[55.426–65.259]

70 (100%)

***(P < 0.001)

0 (0%)
3.608 (2.870)
[2.923–4.292]
0.200 (0.554)
[0.068–0.332]
0.186 (0.460)
[0.076–0.295]
0.811 (2.529)
[0.208–1.413]
9.298 (9.419)
[7.052–11.544]
65.079 (12.778)
[62.032–68.126]
33.112 (10.830)
[30.528–35.693]
9.779 (2.340)
[0.005–0.433]
25.762 (5.546)
[24.440–27.084]
25.706 (5.688)
[24.350–27.062]
83.957 (17.771)
[74.194–82.957]
85.429 (16.444)
[81.508–89.349]
80.500 (13.663)
[77.242–83.758]
69.714 (21.228)
[64.653–74.776]

(P = 0.69)
(P = 0.46)
(P = 0.78)
(P = 0.85)
(P = 0.79)
(P = 0.62)
(P = 0.72)
(P = 0.32)
(P = 0.33)
*(P = 0.03)
*(P = 0.05)
*(P = 0.02)
(P = 0.13)
**(P = 0.01)

*P < 0.05.
**P < 0.01.
***P < 0.001.

also assessed differences between the LS CRC survivors
who were recruited through MD Anderson and those
recruited through social media and found no significant
differences.
As illustrated in Table 2, healthcare utilization was
similar between the LS and sporadic CRC groups. Within
the last 6 months, most had seen their doctors just under
four times and had less than one emergency room visit
or hospital admission. There were no significant differences between LS and sporadic CRC survivors on any
psychosocial measures (CES-
D, Trait, or State anxiety
scales). Satisfaction with social support and family support
showed no differences between the two groups. There
was a significant difference in friend support, with LS
CRC survivors scoring lower than sporadic CRC survivors
(LS = 23.647; sporadic = 25.706; P = 0.03). There were
no differences on any of these variables between the two
recruitment sources for LS survivors.
702

Compared with sporadic CRC survivors, LS survivors
reported lower mean provider satisfaction scores on three
of the PCAS subscales: communication (78.14 vs. 83.96;
P = 0.05), interpersonal treatment (78.58 vs. 85.30;
P = 0.02), and physician’s knowledge of the patient (60.34
vs. 69.86; P = 0.01). There was no statistical difference
in provider trust between the two groups.

Regression analysis
Tables 3 and 4 show the linear regression models for
factors for each of the four PCAS subscales for LS and
sporadic patients, respectively. Among LS CRC survivors,
communication and trust subscales showed similar patterns of predictors. Having more education or having
financial challenges was associated with increased mean
scores for both communication and trust, while being
treated outside of a CCC was associated with lower scores.

© 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
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Table 3. Regression model for patients with LS (n = 73).
Parameter estimate (SE)
Variable

Communication (r2 = 0.458)

Interpersonal (r2 = 0.374)

Trust (r2 = 0.459)

Comprehensive (r2 = 0.384)

Intercept
Age
Female
Not Married
Child
Non-white
<College degree
Postgrad degree
Unemployed
Financial difficulty
Moderate financial difficulty
# Dr. visits
# ER visits
# Hospital stays
# Hospital nights
CES-D
Krause
Lubben family
Lubben friend
Trait
State
Non-CCC

24.737 (23.710)
0.304 (0.225)
0.415 (4.382)
−11.130 (6.708)
−1.782 (6.013)
7.453 (7.914)
7.293 (5.306)
11.879* (5.124)
0.750 (4.848)
13.025* (6.513)
2.874 (4.546)
0.253 (0.605)
−3.996 (4.264)
6.778 (8.287)
−0.050 (1.771)
−0.616 (0.323)
0.192 (0.652)
0.871* (0.410)
0.166 (0.410)
0.125 (0.131)
−0.127 (0.218)
−11.361** (4.061)

37.229 (27.569)
0.245 (0.262)
−0.835 (5.096)
−13.511 (7.799)
−1.170 (6.991)
3.210 (9.202)
4.005 (6.169)
7.205 (5.958)
−0.465 (5.637)
6.256 (7.573)
1.415 (5.286)
0.589 (0.703)
−3.816 (4.958)
11.628 (9.636)
−1.141 (2.059)
−0.664 (0.376)
−0.330 (0.758)
0.810 (0.477)
0.191 (0.477)
0.161 (0.152)
0.092 (0.253)
−7.709 (4.722)

44.851 (21.149)
0.184 (0.201)
−3.204 (3.909)
−9.746 (5.983)
1.527 (5.363)
−2.095 (7.059)
6.882 (4.733)
10.156* (4.570)
−4.079 (4.324)
13.145* (5.810)
5.564 (4.055)
0.250 (0.540)
−4.133 (3.804)
6.813 (7.392)
−0.543 (1.580)
−0.843** (0.288)
−0.039 (0.582)
0.698 (0.366)
0.255 (0.366)
0.022 (0.117)
0.135 (0.194)
−8.786* (3.622)

0.499 (30.675)
0.365 (0.291)
−2.248 (5.670)
−9.131 (8.678)
6.270 (7.779)
13.198 (10.239)
6.443 (6.864)
11.956 (6.629)
−4.071 (6.272)
11.397 (8.426)
8.328 (5.882)
−0.149 (0.783)
0.823 (5.717)
15.531 (10.722)
−3.236 (2.291)
−0.620 (0.418)
0.982 (0.843)
0.959 (0.530)
0.166 (0.530)
−0.004 (0.169)
0.010 (0.282)
−4.286 (5.254)

*P < 0.05.
**P < 0.01.
Table 4. Regression model for sporadic patients (n = 70).
Parameter estimate (SE)
Variable

Communication (R2 = 0.283)

Interpersonal (R2 = 0.312)

Trust (R2 = 0.152)

Comprehensive (R2 = 0.224)

Intercept
Age
Female
Not Married
Child
Non-white
< college degree
Postgrad degree
Unemployed
Financial difficulty
Moderate financial difficulty
# Dr. visits
# ER visits
# hospital stays
# hospital nights
CES-D
Krause
Lubben family
Lubben friend
Trait
State

116.633 (29.030)
−0.588* (0.266)
−8.318 (5.052)
6.170 (7.008)
6.497 (7.235)
−2.661 (10.098)
4.865 (5.492)
−3.095 (6.873)
3.646 (5.603)
1.214 (7.356)
0.647 (5.954)
1.705 (0.968)
−3.907 (4.675)
−0.467 (10.512)
0.602 (1.779)
0.315 (0.388)
0.867 (0.949)
0.182 (0.433)
−0.525 (0.494)
0.058 (0.212)
−0.570* (0.286)

107.639 (26.328)
−0.545* (0.242)
−6.081 (4.582)
2.551 (6.356)
7.081 (6.562)
4.706 (9.158)
3.323 (4.981)
−4.464 (6.232)
5.826 (5.081)
1.613 (6.671)
3.631 (5.340)
1.339 (0.878)
−4.061 (4.240)
3.783 (9.534)
0.283 (1.622)
0.187 (0.351)
1.365 (0.861)
0.183 (0.393)
−0.328 (0.448)
−0.034 (0.193)
−0.448 (0.259)

96.695** (24.280)
−0.389 (0.223)
−2.412 (4.225)
0.995 (5.861)
3.059 (6.051)
0.300 (8.445)
2.909 (4.593)
1.415 (5.748)
3.807 (4.686)
−0.571 (6.152)
2.198 (4.980)
0.567 (0.810)
−2.969 (3.910)
2.485 (8.792)
0.052 (1.496)
−0.033 (0.324)
0.544 (0.794)
0.054 (0.362)
−0.182 (0.413)
0.062 (0.178)
−0.249 (0.239)

34.036 (36.081)
−0.028 (0.331)
−1.658 (6.279)
1.110 (8.710)
7.171 (8.992)
7.068 (12.550)
10.420 (6.826)
1.454 (8.541)
3.804 (6.964)
−3.804 (9.143)
−5.389 (7.400)
2.451* (1.203)
2.101 (5.765)
−9.122 (13.066)
1.845 (2.223)
−0.091 (0.482)
−0.240 (1.179)
−0.119 (0.538)
0.773 (0.614)
0.106 (0.264)
−0.082 (0.355)

*P < 0.05.
**P < 0.01.
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Being treated at healthcare institution that was not a CCC
was a predictor for lower mean scores on communication
(−11.36; P < 0.01) and trust (−8.79; P < 0.05) subscales.
Higher mean depression scores were associated with lower
mean scores on the trust subscale (−0.84; P < 0.01).
Higher mean scores on family support were associated
with higher communication satisfaction scores (0.87;
P < 0.05). There were no significant predictors for the
interpersonal or comprehensive subscale measures.
Regression results for the sporadic CRC survivors differed
from those of the LS survivors. There were no specific predictors for the trust subscale. Age was negatively associated
with the communication and interpersonal subscale scores
for sporadic survivors, indicating that as a patient gets older,
he or she is less satisfied with providers in terms of communication and overall interaction (communication: −0.59;
P < 0.05; interpersonal: −0.55; P < 0.05). Lower mean State
anxiety scores were associated with higher satisfaction scores
for these survivors (−0.57; P < 0.05). Increased utilization
was associated with higher satisfaction with the comprehensive
aspects of provider treatment (2.45; P < 0.05).

Discussion
The goal of this study was to assess patient satisfaction
with their healthcare providers in a sample of CRC survivors both with and without LS. Specifically, we were
interested in comparing these two groups and then assessing factors drawn from the literature that impact these
ratings of HCP satisfaction. Having a better understanding
of these complex patient–provider relationships can both
inform community health providers and assist in the
development of future interventions.
In our study, LS CRC survivors reported lower levels
of satisfaction with their healthcare providers than sporadic
CRC survivors, especially as related to communication,
interpersonal interactions, and knowledge of the patient
as a person. There were no differences between the two
groups in our study in terms of ratings of provider trust.
LS CRC survivors who received care at CCCs reported
higher satisfaction when compared to those receiving care
at other institutions, specifically in terms of communication and trust. Depressive symptoms and socioeconomic
variables also impacted ratings of satisfaction with provider
communication and trust in our LS population. Our finding regarding higher levels of education being associated
with higher provider satisfaction is contrary to what has
been reported in the general oncology literature assessing
overall satisfaction with health care. Specifically, higher
education has been associated with lower levels of satisfaction [44, 45]. However, we also found evidence supporting
increased provider satisfaction for individuals who self-
reported financial concerns. Given that specific qualities
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such as physician skill, provider communication, and physician contact with patients are key components of overall
satisfaction with health care, our contradictory results for
these socioeconomic variables in the LS population merit
additional research [44, 45]. While we found no significant
predictors for the interpersonal or comprehensive subscale
measures, prior research with cancer survivors has shown
that the comprehensive aspects of the provider relationship
(feeling like the provider knows you as a whole person)
as well as higher levels of perceived patient-centeredness
are key factors in overall provider satisfaction [19]. One
of the primary reasons that we were interested in examining factors that predict provider satisfaction in the LS
population is because we know that provider recommendations and provider satisfaction play key roles in patient
adherence to screening and surveillance guidelines and that
nonadherence can be life-
threatening [16–20]. While we
have identified some factors that influence provider satisfaction in LS CRC survivors, further research is needed
in this unique population, particularly in relation to interpersonal and comprehensive aspects of care.
For sporadic CRC survivors, older age, higher anxiety,
and healthcare utilization impacted healthcare provider
satisfaction. Specifically, older survivors reported lower
levels of satisfaction with respect to provider communication and the interpersonal aspects of their care. CRC
survivors who reported higher anxiety also reported lower
levels of satisfaction with patient–provider communication.
Additionally, the more often a patient sees a HCP, the
more satisfied he or she is with how much knowledge
that HCP has about him or her as a person. This finding
aligns with prior research showing that cancer survivors
who are able to ask their providers questions and have
their providers explain things in a way they can understand are more satisfied with their care [46].
Taken together, our study findings provide information
that is relevant to both clinicians and researchers in regard
to factors that influence provider satisfaction in CRC
survivors both with and without LS and contribute to
the small body of literature that exists on provider satisfaction in an oncology setting. We found evidence to
suggest that patients with LS, particularly those who are
being treated outside of CCCs, are less satisfied with
their HCP than sporadic CRC survivors; however, many
of the factors that we hypothesized might predict provider
satisfaction in this population were not significant in our
regression models. Specifically, we expected that both
healthcare experiences and psychosocial factors would
have a greater impact on patient satisfaction with their
HCPs. While some of these variables were significant in
our models, the extent was less than expected based on
the literature. Despite these important conclusions and
comparisons between LS and sporadic CRC survivors,
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we recognize that our study is limited by the small sample
sizes of both groups as well as the potential bias in
recruitment from two different pools of patients with
LS. Recruitment for this hard-to-reach hereditary cancer
population as well as case–case matching was painstakingly undertaken to ensure high-quality data. Additionally,
the control sample is drawn from one CCC, limiting
our ability to assess location of care in the sporadic CRC
population. One other study limitation is the lack of
data on provider specialties as participants were asked
to rate the provider most involved in coordinating his/
her care, but were not asked to identify specialty areas.
This data should be collected in future studies. Given
the above-mentioned factors, the results from this study
may not be generalizable to all CRC survivors with or
without LS.
We believe that the findings from this study contribute
to the scant literature on patient satisfaction with their
HCPs both in the oncology literature generally and in
the LS population specifically. We discovered a gap in
patient satisfaction with their HCPs in these two patient
populations that had not previously been demonstrated
in the literature and also identified predictors of provider
satisfaction that are unique to each of these CRC survivor
populations. We also documented that location of care
is a key factor in determining patient satisfaction with
their HCPs for LS CRC survivors. While these findings
can aid HCPs as well as researchers, we believe that
further research is needed in a larger sample as well as
with qualitative data to more closely examine characteristics of the patient–provider relationship and to identify
additional predictors of patient satisfaction with HCPs.
This work also needs to be expanded to assess the potential impact of patient satisfaction with their HCPs on
adherence to medical management recommendations in
LS CRC survivors, particularly those receiving care outside
of CCCs.
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Supporting Information
Additional supporting information may be found in the
online version of this article:
Table S1. Comparison of LS and sporadic CRC survivors
on study variables.
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